European Parliament does not call for premarket review of IVDs

04/18/2013 | Clinica (subscription required)

In vitro diagnostic products would not be subject to centralized or decentralized premarket approval under a draft report released by the European Parliament on IVD regulation in Europe. Rather, the report calls for improving the system for notified bodies and reinforcing the market oversight and vigilance program, among other recommendations.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX